Home » Stocks » IGC

India Globalization Capital, Inc. (IGC)

Stock Price: $1.88 USD -0.92 (-32.86%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
Market Cap 90.86M
Revenue (ttm) 898,000
Net Income (ttm) -8.81M
Shares Out 45.11M
EPS (ttm) -0.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 23
Last Price $1.88
Previous Close $2.80
Change ($) -0.92
Change (%) -32.86%
Day's Open 2.32
Day's Range 1.86 - 2.36
Day's Volume 23,350,115
52-Week Range 0.55 - 4.65

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Screen capture via IGC's healthcare subsidiary Hyalolex. "Drops of Clarity" is their just-patented Alzheimer's treatment.

Other stocks mentioned: SAVA
1 day ago - Benzinga

What did the stock market do today? Biotech companies took home gains by the armful, and the Fed reopened debate on tapering spending.

Other stocks mentioned: NRXP, SAVA, BASE, DPZ, IPA, UBER
2 days ago - InvestorPlace

India Globalization Capital (AMEX:IGC) shares are trading higher after the company announced the issuance of a patent for the treatment of Alzheimer's disease using THC.  The company was issued a patent...

2 days ago - Benzinga

India Globalization Capital, Inc. (AMEX: IGC) revealed Thursday that it has obtained a patent from the United States Patent and Trademark Office for the treatment of Alzheimer's disease. The patent (#11...

2 days ago - Benzinga

Best high-volume penny stocks for your watchlist right now? Check these 4 out The post Highest Volume Penny Stocks to Watch Today?

Other stocks mentioned: DPLS, EYES, PRFX
2 days ago - PennyStocks

IGC stock is moving up in a huge way today. The company is finally earning its patent for the treatment of Alzheimer's disease with cannabis.

2 days ago - InvestorPlace

POTOMAC, Md.--(BUSINESS WIRE)--IGC Announces Issuance of Patent for the Treatment of Alzheimer's Disease Using THC

2 days ago - Business Wire

Which penny stocks are investors watching with AMC back in focus? The post Top Penny Stocks To Buy Now?

Other stocks mentioned: AUUD, AYRO
3 weeks ago - PennyStocks

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues t...

Other stocks mentioned: AFCG, ARNA, CGC, CRBP, EVGN, OGI, SNDL ...
4 weeks ago - Schaeffers Research

POTOMAC, Md.--(BUSINESS WIRE)-- #IGCAD1--IGC completed Final Cohort of Phase 1 clinical trial on its THC-based investigational new drug intended to alleviate symptoms of Alzheimer's disease.

1 month ago - Business Wire

POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC Reports Financial Results for the Fiscal Year Ended March 31, 2021.

1 month ago - Business Wire

POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC Completes Cohort 2 of its Phase 1 Tetrahydrocannabinol (“THC”)-Based Investigational New Drug Clinical Trial on Alzheimer's Patients.

1 month ago - Business Wire

POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients

2 months ago - Business Wire

POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC got patent (#10,933,082) x its cannabinoid composition & method x treating pain due to Psoriatic Arthritis, Fibromyalgia, Scleroderma & others.

4 months ago - Business Wire

POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC completed administering 1st of 3 levels of dosing of IGC-AD1 on its FDA-approved THC-based phase 1 clinical trial on patients with Alzheimer's.

5 months ago - Business Wire

BETHESDA, Md.--(BUSINESS WIRE)-- #AD--IGC nominated Mr. Lynch as a Class A independent director for election at the Company's 2020 Annual Meeting of Stockholders, to be held on Jan 11 '21.

7 months ago - Business Wire

POTOMAC, MD--(BUSINESS WIRE)-- #AD--India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) announced that it is enrolling participants suffering from mild to severe dementia due...

8 months ago - Business Wire

POTOMAC, Md.--(BUSINESS WIRE)-- #AD--India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the quarter ended September 30, 2020, which...

8 months ago - Business Wire

Shares of Inc. India Globalization Capital IGC, +300.37% surged 26% in premarket trading Thursday, to extend the fourfold rocket ride in the previous session, as they head for an open at the highest le...

11 months ago - Market Watch

India Globalization Capital, Inc. (NYSE: IGC) reported Wednesday with second-quarter revenue of $1.8 million, up 125% from the same quarter in 2018, when it posted $810,000 in revenue.

1 year ago - Benzinga

Holi Hemp, a subsidiary of India Globalization Capital, Inc. (NYSE: IGC), said Thursday that its application for the cultivation and harvesting of hemp was approved by Arizona’s Department of Agricultur...

2 years ago - Benzinga

These stocks to buy are low-priced, top quality choices for growth. Here's what you need to know about each.

Other stocks mentioned: DHT, FSI, REPH, SACH
2 years ago - InvestorPlace

Has the cannabis craze now become tulip mania 2.0?

YouTube video

Raymond James' Dave Novak on whether the pot trade is all smoke and mirrors? With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Brian Kelly, Dan Nathan and Guy Adami.

Other stocks mentioned: CARA, CGC, CRON, GWPH, IIPR, MJ, MO ...
2 years ago - CNBC Television

Cannabis is the new tech, says former Yahoo CEO

YouTube video

Former Yahoo CEO Carol Bartz discusses her investment in cannabis through Caliva on CNBC's "Squawk Alley".

Other stocks mentioned: CGC, CRON, GWPH, TLRY, ABBV, CARA, IIPR ...
2 years ago - CNBC International TV

About IGC

India Globalization Capital, Inc. purchases and resells physical infrastructure commodities. The company operates through two segments, Infrastructure Business, and Life Sciences. It buys and sells infrastructure commodities, such as steel, wooden doors, marble, and tiles; rents heavy construction equipment, including motor grader and rollers; and undertakes highway construction contracts. The company also develops cannabinoid-based products and therapies, such as Hyalolex for the treatment of patients from anxiety, agitation, dementia, depress... [Read more...]

Industry
Conglomerates
Founded
2005
CEO
Ram Mukunda
Employees
50
Stock Exchange
NYSEAMERICAN
Ticker Symbol
IGC
Full Company Profile

Financial Performance

In 2020, IGC's revenue was $898,000, a decrease of -77.95% compared to the previous year's $4.07 million. Losses were -$8.81 million, 20.5% more than in 2019.

Financial Statements